74 research outputs found
Correcting for non-periodic behaviour in perturbative experiments: application to heat pulse propagation and modulated gas-puff experiments
This paper introduces a recent innovation in dealing with non-periodic behavior often referred to as transients. These transients can be the result from unforced response due to the initial condition and other drifts which are a source of error when performing and interpreting Fourier analysis on measurement data. Fourier analysis is particularly relevant in system identification used to build feedback controllers and the analysis of various pulsed experiments such as heat pulse propagation studies. The basic idea behind the methodology is that transients are continuous complex-valued smooth functions in the Fourier domain which can be estimated from the Fourier data. Then, these smooth functions can be approximately subtracted from the data such that only periodic components are retained. The merit of the approach is shown in two experimental examples, i.e., heat pulse propagation (core transport analysis) and radiation front movement due to gas puffing. The examples show that the quality of the data is significantly improved such that it allows new interpretation of the results even for non-ideal measurements.</p
Correcting for non-periodic behaviour in perturbative experiments: application to heat pulse propagation and modulated gas-puff experiments
This paper introduces a recent innovation in dealing with non-periodic behavior often referred to as transients in perturbative experiments. These transients can be the result from the unforced response due to the initial condition and other slow trends in the measurement data and are a source of error when performing and interpreting Fourier spectra. Fourier analysis is particularly relevant in system identification used to build feedback controllers and the analysis of various pulsed experiments such as heat pulse propagation studies. The basic idea behind the methodology is that transients are continuous complex-valued smooth functions in the Fourier domain which can be estimated from the Fourier data. Then, these smooth functions can be subtracted from the data such that only periodic components are retained. The merit of the approach is shown in two experimental examples, i.e. heat pulse propagation (core transport analysis) and radiation front movement due to gas puffing in the divertor. The examples show that the quality of the data is significantly improved such that it allows for new interpretation of the results even for non-ideal measurements
GATA3 Expression Is Decreased in Psoriasis and during Epidermal Regeneration; Induction by Narrow-Band UVB and IL-4
Psoriasis is characterized by hyperproliferation of keratinocytes and by
infiltration of activated Th1 and Th17 cells in the (epi)dermis. By expression
microarray, we previously found the GATA3 transcription factor significantly
downregulated in lesional psoriatic skin. Since GATA3 serves as a key switch in
both epidermal and T helper cell differentiation, we investigated its function
in psoriasis. Because psoriatic skin inflammation shares many characteristics of
epidermal regeneration during wound healing, we also studied GATA3 expression
under such conditions
A novel frequency domain maximum likelihood approach for estimating transport coefficients in cylindrical geometry for nuclear fusion devices
This paper introduces a novel maximum likelihood approach to determine the local thermal transport coefficients belonging to diffusion and convection from excitation (perturbative) transport experiments. It extends previous work developed for linear (slab) geometry to cylindrical (toroidal) geometry for fusion reactors. The previous linear geometry approach is based on analytic solutions of the partial differential equation. However, for cylindrical geometries with convection the analytic solutions are confluent hypergeometric functions (CHFs) with complex valued arguments. Most numerical libraries do not support CHFs evaluation with complex valued arguments. Hence, this paper proposes the use of an ultra-fast transfer function evaluation based on sparse numerical solutions for the discretized partial differential equation. This solution is implemented in MATLAB © and incorporated in the frequency domain Maximum Likelihood Estimation framework. Consequently, transport coefficients can be estimated consistently when measurements are perturbed by coloured and spatially correlated noise
A novel frequency domain maximum likelihood approach for estimating transport coefficients in cylindrical geometry for nuclear fusion devices
This paper introduces a novel maximum likelihood approach to determine the local thermal transport coefficients belonging to diffusion and convection from excitation (perturbative) transport experiments. It extends previous work developed for linear (slab) geometry to cylindrical (toroidal) geometry for fusion reactors. The previous linear geometry approach is based on analytic solutions of the partial differential equation. However, for cylindrical geometries with convection the analytic solutions are confluent hypergeometric functions (CHFs) with complex valued arguments. Most numerical libraries do not support CHFs evaluation with complex valued arguments. Hence, this paper proposes the use of an ultra-fast transfer function evaluation based on sparse numerical solutions for the discretized partial differential equation. This solution is implemented in MATLAB © and incorporated in the frequency domain Maximum Likelihood Estimation framework. Consequently, transport coefficients can be estimated consistently when measurements are perturbed by coloured and spatially correlated noise
T Cell Activation and Proliferation Characteristic for HIV-Nef Transgenic Mice Is Lymphopenia Induced
The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis
BackgroundCurrently available treatment options for Parkinson's disease are symptomatic and do not alter the course of the disease. Recent studies have raised the possibility that cardiovascular risk management may slow the progression of the disease.ObjectivesWe estimated the effect of baseline cardiovascular risk factors on the progression of Parkinson's disease, using measures for PD-specific motor signs and cognitive functions.MethodsWe used data from 424 de novo Parkinson's disease patients and 199 age-matched controls from the observational, multicenter Parkinson's Progression Markers Initiative (PPMI) study, which included follow-up of up to 9 years. The primary outcome was the severity of PD-specific motor signs, assessed with the MDS-UPDRS part III in the “OFF”-state. The secondary outcome was cognitive function, measured with the Montreal Cognitive Assessment, Symbol Digit Modalities Test, and Letter-Number Sequencing task. Exposures of interest were diabetes mellitus, hypertension, body mass index, cardiovascular event history and hypercholesterolemia, and a modified Framingham risk score, measured at baseline. The effect of each of these exposures on disease progression was modeled using linear mixed models, including adjustment for identified confounders. A secondary analysis on the Tracking Parkinson's cohort including 1,841 patients was performed to validate our findings in an independent patient cohort.ResultsMean age was 61.4 years, and the average follow-up was 5.5 years. We found no statistically significant effect of any individual cardiovascular risk factor on the MDS-UPDRS part III progression (all 95% confidence intervals (CIs) included zero), with one exception: in the PD group, the estimated effect of a one-point increase in body mass index was 0.059 points on the MDS-UPDRS part III per year (95% CI: 0.017 to 0.102). We found no evidence for an effect of any of the exposures on the rate of change in cognitive functioning in the PD group. Similar results were observed for the Tracking Parkinson's cohort (all 95% CIs overlapped with PPMI), but the 95% CI of the effect of body mass index on the MDS-UPDRS part III progression included zero.ConclusionsBased on this analysis of two large cohorts of de novo PD patients, we found no evidence to support clinically relevant effects of cardiovascular risk factors on the clinical progression of Parkinson's disease
CTLA-4 regulates allergen response by modulating GATA-3 protein level per cell
T helper type 2 (Th2) cell differentiation requires the expression of GATA-3, a transcription factor that allows transcriptional activation of Th2 cytokine genes through chromatin remodelling. We investigated the role of the negative costimulatory receptor cytotoxic T-lymphocyte antigen 4 (CTLA-4) in the regulation of GATA-3 expression, Th2 differentiation and immunoglobulin production during the immune response to allergens. BALB/c mice were immunized with a recombinant major allergenic component of Parietaria judaica pollen, rPar j I, and treated with blocking anti-CTLA-4 or control antibodies. Results showed that in vivo CTLA-4 blockade enhanced the Par j I-specific immunoglobulin E (IgE) serum level. In contrast, Par j I-specific IgG2a serum level was reduced, suggesting that CTLA-4 blockade skewed immunoglobulin production towards interleukin-4 (IL-4) -dependent immunoglobulin isotypes. Consistently, CTLA-4 blockade increased the frequency of Par j I-specific Th2 cells but not Th1 cells, as well as IL-4 and IL-5 but not interferon-Îł production. Our data also showed that CTLA-4 blockade enhanced the GATA-3 : T-bet messenger RNA ratio. Interestingly, in vivo CTLA-4 blockade did not increase the frequency of GATA-3 protein-expressing cells. In contrast, it enhances GATA-3 protein level per cell. Further, in vitro results show that the anti-CTLA-4 monoclonal antibody, by competing with CD80 for CTLA-4 binding, induced an enhancement in the frequency of IL-4-producing cells that correlates with the increase in GATA-3 protein level per cell. In conclusion, CTLA-4, by affecting the level of GATA-3 per cell, contributes to keeping this factor under the threshold required to become a Th2 effector cell. Consequently, it affects IgE/IgG2a production and contributes to the outcome of allergen-specific immune responses
- …